Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway

BACKGROUND: Paclitaxel (PTX) resistance is a great obstacle for the treatment of ovarian cancer. A previous study indicated that tetrandrine (TET) could induce the apoptosis of ovarian cancer cells. This study aimed to explore the effect of TET in combination with PTX on PTX resistance in ovarian ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Luo, Hou, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200223/
https://www.ncbi.nlm.nih.gov/pubmed/32431514
http://dx.doi.org/10.2147/OTT.S235533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200223/
https://www.ncbi.nlm.nih.gov/pubmed/32431514
http://dx.doi.org/10.2147/OTT.S235533

Ejemplares similares